Roger Douglas Weiss, M.D.
This page shows the publications co-authored by Roger Weiss and Joji Suzuki.
Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2021 04 01; 15(2):91-92.
Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519.
Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286.
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Am J Addict. 2020 03; 29(2):155-159.
Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06.
Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.